🔎 Trials Near Me

Hjem › Crohns sygdom › Illinois › Chicago

Crohns sygdom kliniske forsøg i Chicago, IL

9 studier for Crohns sygdom søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

RekruttererFase 3
  • University of Chicago Medical Center ( Site 5066), Chicago
Alder 16 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

RekruttererFase 2
  • University of Chicago Medical Center /ID# 267400, Chicago
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

RekruttererFase 3
  • Rush University Medical Center, Chicago
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

RekruttererFase 3
  • Rush University Medical Center-Site Number: 8400015, Chicago
Alder 16 til 80 · Alle køn · Opdateret 23. sep. 2026 · NCT07184931

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

RekruttererFase 2
  • Rush University Medical Center, Chicago
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07483073

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

RekruttererFase 2
  • Rush University Medical Center, Chicago
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07483099

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

RekruttererFase 4
  • University of Chicago Medicine, Chicago
Alder 18 til 70 · Alle køn · Opdateret 9. sep. 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Rekrutterer
  • University of Chicago Medicine, Chicago
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT05230173

Treatment of Moderate to Severe Refractory Crohn's Disease

RekruttererFase 1/2
  • Northwestern, Chicago
  • University of Chicago, Chicago
Alder 18 til 65 · Alle køn · Opdateret 10. dec. 2025 · NCT06721962

Crohns sygdom forsøg i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.